S100A9 and myocardial infarction: Collectively, S100a9 lactylation represents a pathological mechanism and probably be a key acute inflammatory target to specifically minimize cardiac neutrophil counts and acute excessive inflammation following MI/R and is a promising alternative biomarker for evaluating acute inflammatory injury and late prognosis.